Atlas Trials

A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines

Clinical trial NCT07756580 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07756580
Sponsor
AbbVie
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Glabellar Lines
Start date
2026-08-10
Primary completion
2027-03-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.